SPONSOR
Xinqiao Hospital of Chongqing
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Lung CancerImmune Checkpoint InhibitorRadiotherapyNSCLC Stage IV Without EGFR/ALK MutationMalignant TumorImmunotherapyArtificial Intelligence
Xinqiao Hospital of Chongqing is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy, NSCLC Stage IV Without EGFR/ALK Mutation.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xinqiao Hospital of Chongqing
How many clinical trials has Xinqiao Hospital of Chongqing sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Xinqiao Hospital of Chongqing, of which 3 are actively recruiting participants. These trials cover conditions including Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xinqiao Hospital of Chongqing research focus on?
Xinqiao Hospital of Chongqing clinical trials span Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy, NSCLC Stage IV Without EGFR/ALK Mutation, Malignant Tumor, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xinqiao Hospital of Chongqing clinical trial?
To participate in a Xinqiao Hospital of Chongqing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xinqiao Hospital of Chongqing trials with current recruitment status updated daily.
Clinical Trials by Xinqiao Hospital of Chongqing
NCT05754203
Recruiting
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Lung Cancer
NCT06947694 Phase 2
Recruiting
A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
NSCLC Stage IV Without EGFR/ALK Mutation
NCT05862259
Recruiting
A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
Malignant Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology